FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

15975111000001109: Ranitidine 150mg tablets (Zanza Laboratories Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Nov 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
56455401000001114 Ranitidine 150mg tablets (Zanza Laboratories Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
110026201000001118 Ranitidine 150mg tablets (Zanza Specials International Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ranitidine 150mg tablets (Zanza Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ranitidine 150mg tablets (Zanza Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Ranitidine 150mg tablets (Zanza Laboratories Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Ranitidine 150mg tablets (Zanza Laboratories Ltd) Is a Product containing precisely ranitidine (as ranitidine hydrochloride) 150 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Ranitidine 150mg tablets (Zanza Laboratories Ltd) Has active ingredient Ranitidine hydrochloride false Inferred relationship Existential restriction modifier
Ranitidine 150mg tablets (Zanza Laboratories Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Ranitidine 150mg tablets (Zanza Laboratories Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ranitidine 150mg tablets (Zanza Laboratories Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Ranitidine 150mg tablets (Zanza Laboratories Ltd) Has specific active ingredient Ranitidine hydrochloride true Inferred relationship Existential restriction modifier
Ranitidine 150mg tablets (Zanza Laboratories Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Ranitidine 150mg tablets (Zanza Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ranitidine true Inferred relationship Existential restriction modifier
Ranitidine 150mg tablets (Zanza Laboratories Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ranitidine 150mg tablets (Zanza Laboratories Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Ranitidine 150mg tablets (Zanza Laboratories Ltd) Has basis of strength substance Ranitidine true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Ranitidine 150mg tablets (Zanza Laboratories Ltd) 60 tablet 4 x 15 tablets Has AMP True Ranitidine 150mg tablets (Zanza Laboratories Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start